---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-163921"
form_type: "8-K"
ticker: "ALMR"
cik: "0002104204"
company_name: "Alamar Biosciences, Inc."
filed_at: "2026-04-20T23:59:59+00:00"
generated_at: "2026-05-15T05:24:09.163628+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Alamar Biosciences closes IPO of 12.9M shares at $17.00, raising ~$219.9M

## Summary
- Completed IPO of 12,937,500 shares of common stock at $17.00 per share, including full exercise of underwriters' option for 1,687,500 shares.
- Aggross gross proceeds of approximately $219.9 million before underwriting discounts and offering expenses.
- Amended and restated certificate of incorporation and bylaws became effective immediately prior to IPO closing.
- Shares now trade on Nasdaq under ticker 'ALMR'.

## SEC filing metadata
- accession: 0001193125-26-163921
- form_type: 8-K
- ticker: ALMR
- cik: 0002104204
- company_name: Alamar Biosciences, Inc.
- filed_at: 2026-04-20T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 5.03, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/2104204/000119312526163921/0001193125-26-163921-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/2104204/000119312526163921/d103481d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-163921
- JSON: https://secwatch.observer/filing/0001193125-26-163921.json
- Plain text: https://secwatch.observer/filing/0001193125-26-163921.txt

## Source-grounded claims
- claim_id: 47485fbbd56a7f54c9a7d52bffddfd8ae2466c60
  claim: Alamar Biosciences, Inc.: Adopted amended and restated bylaws effective April 20, 2026 (effective 2026-04-20).
  evidence_excerpt: Effective as of April 20, 2026, the Company adopted amended and restated bylaws (the “Restated Bylaws”) in connection with the closing of the IPO.
  evidence_url: https://www.sec.gov/Archives/edgar/data/2104204/000119312526163921/0001193125-26-163921-index.htm
- claim_id: 491091ecd3bc339e089acaf93c0dbf326465a6ff
  claim: Alamar Biosciences, Inc.: Filed amended and restated certificate of incorporation effective as of immediately prior to the closing of the IPO on April 20, 2026 (effective 2026-04-20).
  evidence_excerpt: the Company filed an amended and restated certificate of incorporation (the “Restated Certificate”) with the Secretary of State of the State of Delaware. The Company’s board of directors (the “Board”) and stockholders previously approved the Restated Certificate to be effective as of immediately prior to the closing of the IPO.
  evidence_url: https://www.sec.gov/Archives/edgar/data/2104204/000119312526163921/0001193125-26-163921-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.